Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionLeupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cellsAn integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionNeuroendocrine differentiation in prostate cancerAndrogen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survivalRNAi technology and its use in studying the function of nuclear receptors and coregulators.Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer CellsThe many faces of neuroendocrine differentiation in prostate cancer progressionThe dual regulatory role of miR-204 in cancerExpression and functional role of orphan receptor GPR158 in prostate cancer growth and progressionIncreased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptorA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsN-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerIonizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.ORTI: An Open-Access Repository of Transcriptional Interactions for Interrogating Mammalian Gene Expression Data.Transdifferentiation: a cell and molecular reprogramming process.miR 488* inhibits androgen receptor expression in prostate carcinoma cellsThe steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostateMinireview: Alternative activation pathways for the androgen receptor in prostate cancer.Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsAndrogen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cellsThe Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsMechanisms mediating androgen receptor reactivation after castration.Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP CellsChemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cellsRNA editing of androgen receptor gene transcripts in prostate cancer cells.c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.Small cell carcinoma of the prostate.The role of transcription factors in prostate cancer and potential for future RNA interference therapy.A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer.The oncogene ERG: a key factor in prostate cancer.Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.
P2860
Q21129293-97A585D0-9473-4532-AF6C-D2551371E3C1Q24308733-4C14B4E5-25AD-4D10-B3C2-E8D2C14EBDFFQ24313269-0A6E00A6-183E-478C-B602-2DB710082287Q24657547-8C0B3E5B-BEDB-4B91-A92B-0A72EA93C767Q24793296-ACABDD6B-7DA9-4FE3-BBA0-B342F4C5D3B4Q25255053-3F6A58B2-F57D-4B1E-A4D8-03C836A08CC9Q26795738-79C7C5C3-33E4-4B7E-9E32-5B964E30B974Q26992049-A29C5259-C4C7-425E-8ABB-FA064F71C361Q28078421-7B0ADD43-5E86-4E32-9523-D4E2B960A4B7Q28257270-C688EC8D-7FB7-4806-B86B-B3C6496EB750Q28512229-3788CAF3-B697-4D8A-B978-7A0524C3D764Q28573536-1CBADA71-A45C-4BA6-AED1-4948AFF0DF36Q28771715-62D2348B-2D81-4563-B085-7B2DDC7063E4Q30432236-AFB2B40C-338B-4111-9AF3-027D9A89B6D5Q30490157-E9F6BFF4-C7E3-446D-8A78-F775D7FE96A5Q34031587-CAA198C9-2D11-4349-BD6C-02846BB4A0EAQ34196086-25E62CC7-0497-4CFF-8218-38138B4D9816Q34365187-0CA7A605-AB8C-4E9C-8213-016D08BF2CD2Q35001285-6DECA5A6-EFA0-436C-9D48-EC511FEB1050Q35191051-348BB5C9-593E-4B27-AB6B-8A7D0D5279E3Q35221988-7A4236F9-72C9-4C2F-B8C6-CED17166E6A0Q35292006-285D012D-36F8-46B4-B2F9-957FB223212FQ35380936-5797D879-4002-435D-B69A-3F5DAACCCFBCQ35633454-139A60D5-61AF-42F0-AFEA-A18929EBC214Q35665662-32D6F321-3D4F-4D7C-8554-54FA483CB77FQ36132777-6B0272A4-F61D-47D0-BDA5-A80AF17B6C29Q36610457-56E21236-5543-43D6-88A1-78D66ABE923DQ36977833-E7B9E524-E177-4976-9FDC-3B19A8B88B53Q37074738-7C7663EA-A656-4BFD-B97B-E3B0E0247701Q37142544-50F2AC9C-7259-4F13-8A29-609BC4EBADDFQ37688990-F67A8C6B-1C8F-426D-965A-D82CB753ACC5Q38188869-EFEF00D9-8543-47F4-8595-1B78D07723C0Q38198726-457DDA32-8991-4CFC-AA94-C6B64861CF24Q38299437-BDC9465A-022B-4776-B676-531CA2BF87FAQ38399930-217EE57D-D82F-4648-937A-33D9F1446C25Q38444138-D58C1BAC-137D-4EDD-84B4-02F1B0F104B6Q38723072-94E6E8A9-EF50-451B-AF69-8C481FADD604Q38893994-F55C7BA1-67FD-42D4-9102-D4DB4AFBDB8EQ39132563-CC27EC9E-F8D5-4FCC-B215-C778C8EC54BBQ39189709-68D24BDD-E9EB-4E26-9EE5-9E89DBBE4520
P2860
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Androgen receptor represses th ...... cess in prostate cancer cells.
@en
Androgen receptor represses th ...... cess in prostate cancer cells.
@nl
type
label
Androgen receptor represses th ...... cess in prostate cancer cells.
@en
Androgen receptor represses th ...... cess in prostate cancer cells.
@nl
prefLabel
Androgen receptor represses th ...... cess in prostate cancer cells.
@en
Androgen receptor represses th ...... cess in prostate cancer cells.
@nl
P356
P1476
Androgen receptor represses th ...... cess in prostate cancer cells.
@en
P2093
Michael E Wright
Ming-Jer Tsai
P304
P356
10.1210/ME.2003-0031
P577
2003-05-29T00:00:00Z